There might be massive upside ahead for these drugmakers.

Weight loss drugs are the big story in the pharmaceutical industry today, but other opportunities exist, too. Bristol Myers Squibb isn't focused on weight loss, has an attractive yield, and continues ...

Teva Pharmaceutical ADR saw its IBD SmartSelect Composite Rating rise to 98 Thursday, up from 92 the day before.

products industries. Its key products include anti-inflammation drug Stelara, multiple myeloma and light chain amyloidosis drug Darzalex, and nasal spray depression treatment Spravato. Analyst David ...

Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the best healthcare stocks to buy for 2026. Takeda Pharmaceutical ...

Top pharma stocks by Quant Ratings: see Strong Buy/Buy picks across PJP/XPH/PPH—plus why Moderna surged on new cancer-trial ...

Shares of Teva -- a generic-drug maker with a history of losses and high leverage -- have rallied strongly. Pfizer and Merck, which make branded drugs, are financially strong and are rebuilding their ...

The Budget was largely in line with market expectations, barring the hike in securities transaction tax on futures and options, which triggered a broader market sell-off. Outside the ...

Will Budget 2026’s ₹10,000 crore Biopharma Shakti plan transform India into a global biopharma manufacturing hub? Read report ...